Control of Breathing and Acute Respiratory Failure

Published on 11/06/2015 by admin

Filed under Pediatrics

Last modified 11/06/2015

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 3675 times

Chapter 38 Control of Breathing and Acute Respiratory Failure

Because of the brain’s ability to regulate breathing, homeostasis normally is maintained with respect to oxygen, carbon dioxide, and pH despite the presence of serious cardiorespiratory or metabolic disorders. Derangements of respiratory controls may be the primary cause of acute respiratory failure or one of a number of multifactorial causes in a critically ill or injured patient. In other patients, disorders of respiratory regulation prolong dependence on mechanical ventilation.

Respiratory control disorders may be acute or chronic. Long-standing disorders of respiratory controls may be acquired or congenital. When the patient is apneic or has a very slow respiratory rate, the depression of respiratory controls is obvious to the clinician. Functional obstruction of the upper airway may be a clue that neural controls of breathing are impaired. However, many disorders of respiratory controls depress the intensity of respiratory motor neural activity in a more subtle way. Neural depression of breathing may be difficult to distinguish from hypoventilation because of peripheral neuromuscular disease or primary respiratory tract disorders. Recognition of respiratory control disorders may allow specific interventions or, when these disorders cannot be reversed, may enable close monitoring and timely administration of general supportive care, including mechanical ventilation.

This chapter will describe normal respiratory controls, how respiratory controls may fail, and a practical clinical approach to recognition of failed respiratory controls and intervention.

Normal Regulation of Breathing

Rhythmic discharges whose timing corresponds to inspiratory and expiratory phases are generated in motor neurons of the medulla oblongata.1 During comfortable unstimulated breathing, inspiratory motor activity includes diaphragm flattening as well as a mild increase in pharyngeal muscle tone and vocal cord abduction that keep the upper airway patent during inspiratory airflow. When inspiratory muscles relax, resting expiration is passive, driven by elastic recoil of the lung and chest wall. The respiratory rate and motor intensity are modified by a variety of neural, chemical, and mechanical stimuli (Figure 38-1). With high-intensity stimulation, accessory muscles are activated, including intercostals and neck muscles. Nasal flaring occurs. Stimulated breathing also may include end-inspiratory vocal cord closure that acts to prolong lung inflation with little energy expenditure, clinically evident as grunting when the vocal cords open at the beginning of expiration. In highly stimulated breathing, abdominal muscles contract to force expiratory airflow.

Other normal respiratory control behaviors include periodic deep inspirations, sneezing, and coughing to maintain expansion of basal lung areas and clear secretions from the respiratory tract. Breathing is normally coordinated with swallowing and airway protective reflexes to prevent aspiration. Pharyngeal muscle tone is also adjusted with neck flexion and extension to maintain airway patency.

Hypoxemia is a powerful stimulus to ventilation mediated by sensory input originating in the carotid body chemoreceptor. Peripheral chemoreceptor activity and ventilation increase slightly as Pao2 falls below 500 mm Hg. Ventilation rises steeply as Pao2 falls below 50 mm Hg (Figure 38-2, A). Low oxygen tension, rather than low oxygen, content is the ventilatory stimulus. Little carotid body response results from profound anemia. Hydrogen ion concentration and carbon dioxide tension independently activate chemoreceptors in the carotid body and in the brainstem (Figure 38-2, B). The simultaneous presence of hypoxia augments the hypercapnic ventilatory response (Figure 38-2, C).

Mechanical loads on breathing influence respiratory efforts independent of chemical stimuli. Sensors for load-compensating reflexes are located in respiratory muscles and the chest wall. Reduction in lung volume also is detected by pulmonary stretch receptors. Afferent signals travel via the spinal cord, vagus nerves, and perhaps the phrenic nerves. Both conscious and reflex responses are involved in compensatory increases of effort, including the recruitment of accessory muscles in response to increased respiratory resistance or to a decrease in compliance. Stimulation to breathe is further augmented by hypercapnia or hypoxia when loaded breathing reduces ventilation. Respiratory compensation for mechanical loads accounts for the increased respiratory effort in patients who have normal blood gas tension despite acute lung disease. Dyspnea and anxiety may exacerbate the tendency to hyperventilate even without a chemical ventilatory stimulus.

Sleep modifies breathing, and compensation for respiratory illness is most likely to fail during sleep.2 In some persons ventilatory responses to hypercapnia and hypoxia diminish during sleep. Sleep-induced reduction in upper airway tone and cough reflexes worsens the risk of obstruction and aspiration. In infants, whose thorax is compliant, awake lung volume is maintained by thoracic muscle tone and breathing at sufficiently high frequencies that expiration seldom reaches the passive resting lung volume. During sleep, inspiratory muscle tone diminishes and respiratory rate decreases, with resulting reduction in infants’ expiratory lung volume. Infants’ compensation for mechanical loads is compromised during the rapid eye movement stage of sleep more than during quiet sleep. Although sleep is a period of high risk for the sick infant, depriving the patient of sleep is counterproductive. Obstructive and central apnea are worsened by sleep deprivation in healthy infants.3

Genetic factors may account for some variation in respiratory regulation in a normal population,4 but the clinical importance of this variation in predisposing individuals to acute respiratory failure is not clear. Although apnea is common in the premature infant, immaturity of respiratory controls does not otherwise appear to be a risk factor for respiratory failure in infant populations.

Failure of Respiratory Controls

Acute Disorders of Respiratory Controls

Patients with a critical illness or injury generally hyperventilate. At least some of the increased respiratory drive can be attributed to a higher metabolic rate. Pain, discomfort, and fear also stimulate ventilation. When a stressed patient fails to hyperventilate, depressed respiratory controls and impending respiratory failure should be suspected.

Moderate brain injuries typically are associated with hyperventilation (Figure 38-3, B), whether the injury is traumatic, infectious, or hypoxic-ischemic. The hypermetabolic state, lung pathology, and loss of inhibitory cortical influences probably combine to augment ventilation. Even when the brain-injured patient does hyperventilate, airway protective reflexes usually are impaired, seizures may ensue, and subtle progression of the brain lesion may lead to hypoventilation (Figure 38-3, A, CtoE). Resulting hypoxia may exacerbate the brain injury.

Seizures impair breathing in various ways. Apnea or slowing of respiratory rate, impairment of upper airway protective reflexes, and poor inspiratory effort are common. The clinician must have a high index of suspicion to recognize occult seizures. The seizure-induced respiratory depression may be difficult to distinguish from the brain pathology that may have caused the seizure, as well as the respiratory-depressing effects of anticonvulsant medications.

Respiratory depression by analgesic drugs, sedative agents, anticonvulsant medications, and anesthetic drugs is common. Opiates, benzodiazepines, barbiturates, and propofol all have respiratory-depressing effects. Relative effects on upper airway patency and hypoxic, hypercapnic, and loading responses may be dissociated. For example, Chloral hydrate has little effect on chemosensitivity but reduces genioglossus muscle tone and predisposes to obstructive apnea. Concern regarding respiratory depression does not warrant withholding analgesia. Rather, monitoring should be appropriate. In fact, episodic hypoxia during treatment procedures may be reduced when appropriate analgesia is provided.5 Sedative agents and analgesic drugs that are rapidly cleared after a single dose may have a more prolonged duration of action when given repeatedly or continuously. Clearance rates for medications may vary with systemic disease, immaturity, or genetic factors. Sedation and analgesic-induced respiratory depression may prolong the need for mechanical ventilation. Substituting an agent that clears rapidly (such as remifentanil) for longer acting agents several hours before a planned extubation may facilitate weaning from mechanical ventilation. Dexmedetomidine, an α2 adrenergic agonist, may provide sedation with less respiratory depression than other agents.

Buy Membership for Pediatrics Category to continue reading. Learn more here